Simultaneous and staged bilateral TJA yielded similar episode-of-care costs

Results published in The Journal of Arthroplasty showed no differences in the 90-day episode-of-care costs among Medicare patients who underwent either simultaneous or staged bilateral total joint arthroplasty. Researchers recorded demographics, comorbidities, readmission rates and 90-day episode-of-care costs based on CMS claims data among 319 patients undergoing simultaneous primary TJA and 168 patients undergoing staged TJA. To identify independent risk factors for increased costs, researchers performed a multivariate regression analysis. Although results showed no differences between staged